Insmed, Inc. (INSM)
195.55
+0.31
(+0.16%)
USD |
NASDAQ |
Dec 12, 12:33
Insmed Research and Development Expense (Quarterly): 186.42M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| United Therapeutics Corp. | 127.50M |
| Alnylam Pharmaceuticals, Inc. | 358.81M |
| Madrigal Pharmaceuticals, Inc. | 173.65M |
| Vertex Pharmaceuticals, Inc. | 977.70M |